OH2 Injection in Combination With HX008 for Melanoma.

NCT04616443 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Binhui Biopharmaceutical Co., Ltd.